arginine has been researched along with Auricular Fibrillation in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (15.79) | 29.6817 |
2010's | 28 (73.68) | 24.3611 |
2020's | 4 (10.53) | 2.80 |
Authors | Studies |
---|---|
Antoku, Y; Koga, T; Nyuta, E; Sakai, T; Takemoto, M; Tsuchihashi, T; Ueno, J | 1 |
Alonso-Gómez, Á; Arós, F; Atzeni, A; Babio, N; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fiol, M; Fitó, M; Gómez-Gracia, E; Goni, L; Guasch-Ferré, M; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MA; Razquin, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wittenbecher, C | 1 |
Bavendiek, U; Biber, S; Bode-Böger, SM; Gabriel, MM; Grosse, GM; Lichtinghagen, R; Martens-Lobenhoffer, J; Schuppner, R; Sieweke, JT; Weissenborn, K; Worthmann, H; Ziegler, NL | 1 |
Bahls, M; Böger, RH; Büttner, P; Hindricks, G; Kornej, J; Schwedhelm, E; Thiele, H | 1 |
Bocian, K; Fiszer, U; Korczak-Kowalska, G; Leńska-Mieciek, M | 1 |
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A | 1 |
Cooke, JP; Sukhovershin, RA | 1 |
Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI | 1 |
Heresztyn, T; Horowitz, JD; Nguyen, TH | 1 |
Csecsei, P; Farkas, N; Illés, Z; Kéki, S; Molnár, T; Nagy, L; Szapáry, L; Várnai, R | 1 |
Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC | 1 |
Azuma, S; Lum, CJ | 1 |
Agho, K; Attia, J; Mangoni, AA; McEvoy, M; Peel, R; Schofield, P; Smith, W; Soiza, RL | 1 |
Hatakeyama, M; Munakata, M; Ono, Y | 1 |
Hirayama, A; Kogawa, R; Mano, H; Nagashima, K; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I | 1 |
Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD | 1 |
Lip, GY; Polovina, MM; Potpara, TS | 1 |
Beer, JC; Cottin, Y; Guenancia, C; Lorgis, L; Lorin, J; Rochette, L; Stamboul, K; Touzery, C; Vergely, C; Zeller, M | 1 |
Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W | 1 |
Appelbaum, S; Atzler, D; Bauer, C; Blankenberg, S; Böger, RH; Hoffmann, B; Lackner, KJ; Münzel, T; Ojeda, FM; Ramuschkat, M; Schnabel, RB; Schwedhelm, E; Sinning, CR; Wild, PS; Zeller, T | 1 |
Atzler, D; Benjamin, EJ; Böger, RH; Ellinor, PT; Larson, MG; Levy, D; Lubitz, SA; Maas, R; Magnani, JW; McManus, DD; Schnabel, RB; Schwedhelm, E; Vasan, RS; Wang, N; Yin, X | 1 |
Kaminskas, E; Reiffel, JA; Reilly, P; Sager, P; Sarich, T; Seltzer, J; Weitz, JI | 1 |
Chen, XL; Gao, XR; Lao, MC; Liu, LJ; Lu, GH; Luo, CF; Zhai, YS | 1 |
Kaatz, S; Milling, TJ | 1 |
Feng, W; Qu, X; Song, Y; Xia, W; Yu, Y; Zhang, X | 1 |
Chen, W; Liang, Z; Liu, H; Qu, X; Song, Y; Xia, W | 1 |
Li, J; Qu, X; Song, Y; Xia, W; Yin, Z | 1 |
Bode-Böger, SM; Bukowska, A; Dobrev, D; Goette, A; Hammwöhner, M; Lendeckel, U; Martens-Lobenhoffer, J; Medunjanin, S; Ravens, U; Scalera, F; Weinert, S | 1 |
Arnesen, H; Bratseth, V; Seljeflot, I; Smith, P; Tveit, A | 1 |
Jain, PG; Kauflin, MJ; Nanda, MM; Yannetta, JC | 1 |
Bonilla, I; Cardounel, AJ; Carnes, CA; Elton, TS; Györke, S; Khan, M; Kuppusamy, P; Li, C; Nishijima, Y; Sridhar, A; Terentyev, D; Terentyeva, R; Velayutham, M; Zweier, JL | 1 |
Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S | 1 |
Feng, W; Li, J; Qu, X; Xia, W | 1 |
Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I | 1 |
Alasady, M; Brooks, AG; Gan, C; Kalman, JM; Kistler, PM; Lau, DH; Leong, DP; Lim, HS; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD | 1 |
Bhatt, DL; Gurm, HS | 1 |
Biberoğlu, G; Cengel, A; Hasanoğlu, A; Ozdemir, M; Sahinarslan, A; Tavil, Y; Tulmaç, M | 1 |
Chevalier, A; Nutescu, EA; Shapiro, NL | 1 |
6 review(s) available for arginine and Auricular Fibrillation
Article | Year |
---|---|
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2019 |
Endothelial (dys)function in lone atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; E-Selectin; Endocardium; Endothelium, Vascular; Humans; Predictive Value of Tests; Prognosis; Risk Factors; Thrombomodulin; von Willebrand Factor | 2015 |
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank.
Topics: Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Arginine; Atrial Fibrillation; Congresses as Topic; Dabigatran; Drug Monitoring; Factor Xa; Factor Xa Inhibitors; Humans; Partial Thromboplastin Time; Piperazines; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thiazoles; Thrombin Time; Venous Thromboembolism | 2016 |
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
Topics: Animals; Antidotes; Arginine; Atrial Fibrillation; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thromboembolism | 2016 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
New anticoagulant agents: direct thrombin inhibitors.
Topics: Anticoagulants; Arginine; Atrial Fibrillation; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Half-Life; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Pyridines; Recombinant Proteins; Stroke; Sulfonamides; Thrombin | 2008 |
4 trial(s) available for arginine and Auricular Fibrillation
Article | Year |
---|---|
Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Electric Countershock; Female; Humans; Male; Middle Aged; Prognosis; Reproducibility of Results; Secondary Prevention; Sensitivity and Specificity; Treatment Outcome | 2008 |
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Electric Countershock; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides | 2009 |
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Female; Humans; Male; Middle Aged; Recurrence; Tetrazoles; Time Factors | 2010 |
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Arginine; Atrial Fibrillation; Biomarkers; Bisoprolol; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase, MB Form; Drug Administration Schedule; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Natriuretic Peptide, Brain; Pilot Projects; Serum Amyloid P-Component; Single-Blind Method; Time Factors; Treatment Outcome; Troponin I; Urea | 2012 |
28 other study(ies) available for arginine and Auricular Fibrillation
Article | Year |
---|---|
Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor.
Topics: Aged; Antithrombins; Arginine; Atrial Fibrillation; Catheter Ablation; Heparin; Humans; Male; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2022 |
Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial.
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Case-Control Studies; Diet, Mediterranean; Heart Failure; Humans; Mediterranea; Risk Factors | 2022 |
Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Carotid Intima-Media Thickness; Electrocardiography; Embolism; Endothelium; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; ROC Curve; Statistics, Nonparametric; Stroke | 2019 |
Arginine derivatives in atrial fibrillation progression phenotypes.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Disease Progression; Female; Homoarginine; Humans; Male; Middle Aged; Phenotype | 2020 |
Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances.
Topics: Arginine; Atrial Fibrillation; Brain Ischemia; Carotid Intima-Media Thickness; Humans; Lysine; Risk Factors; Stroke | 2020 |
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis | 2017 |
Novel Markers for Adverse Events in Atrial Fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Humans | 2018 |
Risk indexation and atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Humans | 2019 |
L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Brain Ischemia; Humans; Stroke | 2019 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Referral and Consultation; Risk Assessment; Risk Factors; Stroke; Survival Rate; Time Factors | 2013 |
A comparison of methods for estimating glomerular filtration rate for a population in Hawai'i with non-valvular atrial fibrillation.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Glomerular Filtration Rate; Hawaii; Humans; Male; Morpholines; Pipecolic Acids; Retrospective Studies; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2013 |
Memory impairment is associated with serum methylarginines in older adults.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cohort Studies; Diabetes Mellitus; Educational Status; Female; Humans; Logistic Models; Male; Memory Disorders; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Odds Ratio; Severity of Illness Index | 2014 |
Thrombosis of biatrial appendages due to heparin-induced thrombocytopenia.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Arginine; Arterial Occlusive Diseases; Atrial Appendage; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Drug Administration Schedule; Drug Substitution; Female; Heart Diseases; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2013 |
Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.
Topics: Adiponectin; Arginine; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Catheter Ablation; Diagnostic Imaging; Echocardiography; Electrocardiography; Extracellular Matrix; Female; Humans; Inflammation; Interleukin-6; Male; Matrix Metalloproteinase 2; Middle Aged; Predictive Value of Tests; Recurrence; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Treatment Outcome | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Prospective Studies; Recurrence; Stroke | 2014 |
Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Liquid; Electrocardiography; Endothelium; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Oxidative Stress; Risk Assessment; Risk Factors | 2015 |
Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation.
Topics: Aged; Arginine; Atrial Appendage; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Nitric Oxide; Thrombosis | 2015 |
ADMA, subclinical changes and atrial fibrillation in the general population.
Topics: Adult; Aged; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, Liquid; Echocardiography; Electrocardiography; Female; Germany; Humans; Male; Middle Aged; Morbidity; omega-N-Methylarginine; Oxidative Stress; Population Surveillance; Tandem Mass Spectrometry | 2016 |
Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Oxidative Stress; Proportional Hazards Models; Reproducibility of Results; Statistics as Topic | 2016 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thrombosis | 2016 |
Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
Topics: Amidohydrolases; Animals; Arginine; Atrial Fibrillation; Disease Models, Animal; Dogs; Down-Regulation; Endothelium; Female; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases; Thrombosis; Up-Regulation | 2008 |
The impact of rapid atrial pacing on ADMA and endothelial NOS.
Topics: Aged; Animals; Arginine; Atrial Fibrillation; Calcium-Binding Proteins; Disease Models, Animal; Endothelium, Vascular; Female; Heart Rate; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide Synthase Type III; Oxidative Stress; Pacemaker, Artificial; Risk Factors; Swine; Tachycardia; Ventricular Function, Left | 2012 |
Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Topics: Aged; Anticoagulants; Arginine; Atrial Fibrillation; Blood Coagulation Tests; Carotid Stenosis; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Warfarin | 2011 |
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.
Topics: Action Potentials; Animals; Arginine; Atrial Fibrillation; Atrial Function, Left; Biopterins; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Female; Heart Atria; Heart Failure; Kinetics; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Patch-Clamp Techniques; Superoxides; Up-Regulation; Ventricular Function, Left | 2011 |
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Body Surface Potential Mapping; Catheter Ablation; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.
Topics: Animals; Apoptosis; Arginine; Atrial Fibrillation; Atrial Function, Left; Dogs; Echocardiography, Transesophageal; Female; Fluorobenzenes; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Nitric Oxide; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Heart Atria; Heart Rate; Humans; Male; Middle Aged; P-Selectin; Peptide Hydrolases; Platelet Activation; Risk Assessment; Risk Factors; Statistics as Topic; Stroke; Thrombosis | 2013 |
Asymmetrical dimethylarginine level in atrial fibrillation.
Topics: Acute Disease; Arginine; Atrial Fibrillation; Chromatography, High Pressure Liquid; Chronic Disease; Humans; Middle Aged | 2008 |